Shares of Dave Inc. plunged 10.2% to $302.00 in pre-market trading on November 5, erasing a 6.8% rally the prior session, after the neobank's third-quarter earnings report exposed cracks beneath an otherwise gleaming top line. The stock had already dropped 7.8% in after-hours trading to $310.00 immediately following the release. The broader financial sector was higher, isolating Dave's selloff as company-specific.

Revenue Crushed Estimates, But That Wasn't Enough

Revenue hit $198 million, up 31% year-over-year, comfortably beating the $191.6 million analyst forecast.

Dave added a record 1.1 million new members, up 35%, with the cost to acquire each one rising only 14% to $22. Yet the stock cratered because investors fixated on the bottom line: adjusted earnings per share of $4.39 slipped below last year's $4.45 , and adjusted EBITDA of $81.5 million narrowly missed the $82.6 million forecast. When a stock trades at roughly 21× trailing earnings, even a penny of disappointment invites profit-taking.

A $37 Million Credit Bill Rattled the Margin Story

The provision for credit losses—money set aside for borrowers who don't repay—was $37 million, or about 1.5% of the $2.5 billion originated.

That came in above the company's own forecast due to a recalibration of repayment-timing assumptions, dragging gross margin from 72% in Q2 down to 70%. Management partly blamed higher funding costs from its banking partner. Last quarter, the CFO had projected margins expanding "into the mid-70s" —that promise now looks premature, and markets punished the gap between expectation and delivery.

Raised Guidance Signals Confidence—But the Bar Also Rises

Dave lifted full-year 2026 targets to $746–$750 million in revenue, $327–$330 million in adjusted EBITDA, and $17.45–$17.65 in adjusted EPS.

The implied Q4 outlook calls for roughly $221 million in revenue (~35% growth) and a 46% adjusted EBITDA margin —both significant step-ups. Management says Q4 delinquency rates are tracking below 2.00% and expects gross margin to rebound above Q2 levels. If that materializes, today's selloff may look like overreaction. If not, a stock trading well above independent fair-value estimates near $189 faces a long way down.

Regulatory Overhang Adds a Wild Card

Litigation-related expenses rose sharply, with unresolved DOJ/FTC and state-level investigations posing risk to the core small-dollar lending model. For a company whose entire revenue engine depends on short-term cash advances, regulatory scrutiny is not a side issue—it is the existential question investors must price alongside the impressive growth numbers.